Content about New Drugs & OTCs

August 12, 2013

Teva Pharmaceutical and Perrigo Co. announced the launch of the generic equivalent to Temodar (temozolomide). Teva will manufacture, market and distribute the product in the United States, and both companies will equally share in the cost and profitability of the product in the country.

August 8, 2013

Eisai announced that the Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous T-cell lymphoma.

August 8, 2013

Keryx Biopharmaceuticals announced the submission of a new drug application to the Food and Drug Administration seeking approval for the marketing and sale of Zerenex (ferric citrate coordination complex), the company's drug candidate for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with chronic kidney disease on dialysis.

August 6, 2013

Actavis has acquired global rights to a drug made by a Spanish company for fungal infections of the vagina, the companies said Tuesday.

August 5, 2013

Amneal Pharmaceuticals has introduced five new generic drugs, the company said.

August 5, 2013

The Food and Drug Administration has approved for shipment the latest version of a GlaxoSmithKline flu vaccine, the drug maker said Monday.

August 5, 2013

A new treatment for bacterial infections of the vagina is now available, the drug's manufacturer said.

August 2, 2013

The Food and Drug Administration has approved a vaccine against meningococcal disease for use among patients of a broader age range than before.

July 31, 2013

The Food and Drug Administration has approved a Perrigo generic drug for treating dermatitis, the company said Wednesday.

July 31, 2013

The Food and Drug Administration has given Lupin Pharmaceuticals tentative approval to two of its products, the company said Wednesday.

July 31, 2013

Nearly 450 drugs are under development for treating neurological disorders, according to a report by a drug industry trade group.

July 29, 2013

Actavis hopes to become the first to market a generic drug for treating chronic pain, the company said.

July 29, 2013

Actavis is launching new formulations of a drug used to treat tension headaches, the company said Monday.

July 29, 2013

Dr. Reddy's Labs has launched a generic drug used to treat Alzheimer's disease, the company said.

July 29, 2013

Reckitt Benckiser will be launching a product for nighttime cold and flu relief in both liquid and tablet form, the company's CEO told investors Monday morning.

July 25, 2013

Mylan and Orion Corp. have settled a patent-infringement suit over a drug used to treat Parkinson's disease.

July 24, 2013

Canadian regulators have approved two drugs made by GlaxoSmithKline for treating skin cancer.

July 24, 2013

Miraculins announced the launch of its PreVu Non-Invasive Skin Cholesterol Point of Care Test exclusively through some 20 H-E-B locations over fourth quarter 2013.

July 24, 2013

Mylan has settled with the makers of a drug used to treat cancer in a patent-infringement lawsuit, the generic drug maker said.

July 23, 2013

The Food and Drug Administration has approved a generic diabetes drug made by Lupin, the company said.

July 22, 2013

The Food and Drug Administration has approved a drug made by Japanese drug maker Astellas for preventing the body from rejecting transplanted organs, the company said.

July 22, 2013

Fuse Science's new products ElectroFuse and PowerFuse were named "Best New Products" by retailers attending ECRM's Diet, Vitamin and Sports Nutrition conference.

July 22, 2013

An announcement Monday by generic drug maker Sandoz gives a glimpse of what could happen in the United States when biosimilars start to become available.

July 22, 2013

Drug maker Teva Pharmaceutical Industries has introduced acitretin capsules, the company said.

© 2014 Drug Store News. All Rights Reserved.